Search Medical Condition
Please enter condition
Please choose location from dropdown
Clear Trial Filters
 

E Watertown, Massachusetts Clinical Trials

A listing of E Watertown, Massachusetts clinical trials actively recruiting patient volunteers.

RESULTS

Found (739) clinical trials

AGN-241751 in the Treatment of Major Depressive Disorder

To evaluate the efficacy at 1 day post initial oral dose of AGN-241751 compared with placebo in participants with MDD

Phase

6.7 miles

Learn More »

Do you suffer from anxiety? Are you often feeling stressed, worried, restless? Boston Clinical Trials is enrolling in a new research study for Generalized Anxiety Disorder.

Phase N/A

6.7 miles

Learn More »

Has this traumatic event that has caused lingering effects like anxiety, insomnia or nightmares? Boston Clinical Trials is conducting a new study for post traumatic stress disorder (PTSD.)

Phase N/A

6.7 miles

Learn More »

Efficacy and Safety Trial of Rimegepant for Migraine Prevention in Adults

The purpose of this is study is to compare the efficacy of BHV-3000 (rimegepant) to placebo as a preventive treatment for migraine, as measured by the reduction in the number of migraine days per month.

Phase

6.7 miles

Learn More »

walk2Wellness: Long-term Effects of Walkasins Wearable Sensory Prosthesis

The main objective of the current study is to show a long-term (10 weeks) sustained improvement in FGA score >4 following walkasins use as compared to initial baseline assessment and to examine a potential relationship between initial baseline assessment data and long-term outcome. The finding of a short-term FGA change ...

Phase N/A

6.7 miles

Learn More »

Study of Safety and Efficacy of Tropifexor (LJN452) in Patients With Non-alcoholic Steatohepatitis (NASH)

The purpose of the study is to assess the effects of different doses of tropifexor (LJN452) with respect to safety, tolerability, and on markers of liver inflammation in patients with NASH

Phase

6.74 miles

Learn More »

The Effects of Multi-focal tDCS on Motor-cognitive Dysfunctions in Parkinson's Disease

The current study aim to establish the therapeutic potential of tDCS for freezing of gait (FOG) and motor-cognitive dysfunctions in Parkinson's Disease (PD). FOG phenomenon is often unresponsive to pharmacological and other treatments, especially in the advanced stages of the disease. While it is likely that Transcranial direct current stimulation ...

Phase N/A

6.79 miles

Learn More »

Clinical Proteomic Research for the Brain

The purpose of this study is to learn how the brain responds to vascular injuries such as stroke and/or to various medical or surgical treatments. The researchers will do this by examining naturally occurring proteins in the blood and urine using state-of-the-art proteomics techniques. Proteomics enables a "snapshot" of the ...

Phase N/A

6.81 miles

Learn More »

Study Comparing the Safety and Efficacy of IDP-120 Gel and IDP-120 Vehicle Gel in the Treatment of Acne Vulgaris

This is a multi-center, randomized, double-blind, vehicle-controlled, 12-week study designed to assess the safety, tolerability, and efficacy of IDP-120 Gel and IDP-120 Vehicle Gel at Weeks 2, 4, 8, and 12. To be eligible for the study subjects must be at least 9 years of age and have a clinical ...

Phase

6.82 miles

Learn More »

The VOLTAIRE-X Trial Looks at the Effect of Switching Between Humira and BI 695501 in Patients With Plaque Psoriasis.

The primary objective of the trial is to assess the PK similarity between patients receiving Humira continuously vs those who alternate between BI 695501 and Humira, in patients with moderate-to-severe chronic plaque psoriasis. The secondary objectives of this trial are to descriptively compare the safety, immunogenicity and efficacy profiles between ...

Phase

7.38 miles

Learn More »